Reviva Pharmaceuticals (RVPH) Q1 2026 Earnings

30MarConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-1.89
-1.02
-0.15
0.72

Details

Expected EPS
-1.08
Actual EPS
0.72
Surprise EPS
1.8
Surprise Percent
+166.67%

Description

Reviva Pharmaceuticals (RVPH) has reported earnings of 0.72 per share for Q1 2026.

0 Comments

Share your thoughts